{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:03:37Z","timestamp":1776359017829,"version":"3.51.2"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["HX-H2509398"],"award-info":[{"award-number":["HX-H2509398"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,3]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>For critically ill patients requiring continuous renal replacement therapy, regional citrate anticoagulation is the preferred strategy to maintain extracorporeal circuit patency. Current clinical practice relies on two citrate-based protocols, with the widely used but complex 4% trisodium citrate solution posing a hypernatraemia risk and haemofiltration replacement fluid of sodium citrate offering procedural simplification and a more physiological electrolyte profile. Direct prospective comparison of their circuit lifespan efficacy is currently unavailable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This single-centre, prospective, open-label, parallel-group randomised controlled trial will be conducted in China. 90 patients will be enrolled and randomly assigned (1:1) to receive anticoagulation with either citrate-based haemofiltration replacement fluid or 4% trisodium citrate solution, with all patients undergoing a standardised continuous venovenous haemofiltration protocol. The primary outcome is circuit lifespan, with a non-inferiority margin set at 2.43\u2009hours. Secondary outcomes include the 72-hour circuit survival probability, duration of hospitalisation, and all-cause mortality rates at 28 and 90 days. The primary analysis will follow the intention-to-treat principle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol has been approved by the Biomedical Research Ethics Committee of West China Hospital, Sichuan University (Approval No. (2025)1157). Any subsequent amendments must be submitted to the same ethics committee for further review and approval prior to implementation. Furthermore, the findings of this trial will be disseminated through presentations at relevant national and international conferences and via publication in peer-reviewed scientific journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry ChiCTR2500106991.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-115862","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:15:46Z","timestamp":1776356146000},"page":"e115862","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prefilled versus infused regional citrate anticoagulation during continuous renal replacement therapy on circuit lifespan: protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"16","author":[{"given":"Hongxia","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niroj","family":"Mali","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-4802","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026041609151729000_16.4.e115862.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3934-7"},{"key":"2026041609151729000_16.4.e115862.2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5937"},{"key":"2026041609151729000_16.4.e115862.3","unstructured":"Kellum J , Lameire N , Aspelin P , et al . Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl (2011) 2012;1\u2013138."},{"key":"2026041609151729000_16.4.e115862.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04519-1","article-title":"Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2023","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01280214"},{"key":"2026041609151729000_16.4.e115862.6","doi-asserted-by":"publisher","DOI":"10.1186\/cc11645"},{"key":"2026041609151729000_16.4.e115862.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-025-05648-5","article-title":"Clinical and biological profiles associated with the time of occurrence of citrate accumulation in patients receiving continuous renal replacement therapy","volume":"29","author":"Bidar","year":"2025","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-017-1870-3","article-title":"Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction","volume":"21","author":"Klingele","year":"2017","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","article-title":"Complications of regional citrate anticoagulation: accumulation or overload?","volume":"21","author":"Schneider","year":"2017","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","article-title":"Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2019","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05867-8","article-title":"Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT","volume":"12","author":"Thanapongsatorn","year":"2022","journal-title":"Sci Rep"},{"key":"2026041609151729000_16.4.e115862.12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2215\/CJN.0000000000000351","article-title":"Regional Citrate Anticoagulation versus No Anticoagulation for CKRT in Patients with Liver Failure with Increased Bleeding Risk","volume":"19","author":"Bai","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026041609151729000_16.4.e115862.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0472-6","article-title":"Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial","volume":"18","author":"Schilder","year":"2014","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.14","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181953c5e"},{"key":"2026041609151729000_16.4.e115862.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0822-z","article-title":"Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial","volume":"19","author":"Stucker","year":"2015","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","article-title":"Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"20","author":"Liu","year":"2016","journal-title":"Crit Care"},{"key":"2026041609151729000_16.4.e115862.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.10.015"},{"key":"2026041609151729000_16.4.e115862.18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1751143717695835","article-title":"Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation following a change in practice","volume":"18","author":"Borg","year":"2017","journal-title":"J Intensive Care Soc"},{"key":"2026041609151729000_16.4.e115862.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-019-1648-8","article-title":"Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis","volume":"20","author":"Lenga","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026041609151729000_16.4.e115862.20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0972-5229.198311","article-title":"Experiences with Continuous Venovenous Hemofiltration using 18mmol\/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution","volume":"21","author":"Jeffrey","year":"2017","journal-title":"Indian J Crit Care Med"},{"key":"2026041609151729000_16.4.e115862.21","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00040505"},{"key":"2026041609151729000_16.4.e115862.22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2026041609151729000_16.4.e115862.23","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"2026041609151729000_16.4.e115862.24","first-page":"1259","article-title":"Anticoagulant efficacy of a novel citrate-containing calcium-free replacement fluid in hemodialysis for critically ill patients","volume":"45","author":"Hu","year":"2020","journal-title":"J PLA Med J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-115862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:15:51Z","timestamp":1776356151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-115862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-115862"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-115862","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}